Company profile

FUJIFILM Healthcare Americas

Medical Imaging & Radiology

Company profile

About FUJIFILM Healthcare Americas

FUJIFILM Healthcare Americas Corporation is a leading provider of comprehensive healthcare solutions with a legacy spanning over 90 years since launching its healthcare business with x-ray film in 1936. The company delivers an extensive portfolio of medical imaging and diagnostic technologies designed to support every step of the patient's health journey, from prevention to diagnosis and treatment. Their solutions encompass diagnostic imaging (digital radiography, CT, MRI, ultrasound, mammography), enterprise imaging through the Synapse platform, endoscopic imaging systems, surgical imaging and planning tools, and in vitro diagnostics including liver cancer biomarkers. FUJIFILM Healthcare serves diverse healthcare stakeholders including hospitals, health systems, imaging centers, surgical facilities, and specialty practices. The company offers specialized imaging solutions for unique patient populations including rural health, pediatrics, orthopedics, women's health, and veterinary care. With continuous investment in research and development, FUJIFILM Healthcare remains committed to advancing the fields of prevention, diagnosis, and treatment while providing world-class imaging solutions and comprehensive post-sales support to healthcare organizations.

Company description FUJIFILM Healthcare Americas official website

Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at FUJIFILM Healthcare Americas?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Cardiovascular conditions
  • Gastroenterology conditions
  • Liver cancer (HCC)
  • Neonatal/pediatric conditions
  • Neurosurgery
  • Orthopedic conditions
  • Pulmonary conditions
  • Surgical oncology
  • Urology
  • Women's health

Who it serves

  • Critical Access Hospitals
  • Health Systems
  • Hospitals
  • Imaging Centers
  • Rural Health Facilities
  • Specialty Practices
  • Surgical Facilities
  • Veterinary Clinics

Deployment & integration

Cloud Saas · Hybrid deployment with recorded integration context.

Recorded integration context: Cerner, Epic, Synapse EIS/RIS, Synapse Enterprise PACS, Synapse VNA, Synapse Worklist Orchestrator.

Geographic context

MarketsAmericas region · United States
Company sourceOfficial website

Company milestones

Platform expansion

Opened new Endoscopy Warehouse Facility in Fairfield, NJ (2026); Launched EB-710US balloon-less EBUS bronchoscope (May 2026); Partnership with mTuitive for precision medicine (May 2026)

Partnerships

Recorded partners

  • mTuitive (precision medicine partnership announced May 2026)
  • Various health systems and hospitals

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Radiology Solutions

Comprehensive radiology PACS with integrated AI capabilities

Platform · HybridCompany source

Cardiology Solutions

Specialized PACS solution for cardiology imaging workflows

Platform · HybridCompany source

Synapse 3D

AI-ready advanced visualization for image analysis and treatment planning

Software · HybridCompany source

Synapse AI Orchestrator

Open imaging workflow orchestrator with advanced rules engine for AI algorithm integration

Platform · HybridCompany source

Synapse Enterprise PACS

Unified, cloud-enabled diagnostic viewer with cross-departmental image access

Platform · Cloud SaaSCompany source

Synapse Pathology

Vendor-agnostic pathology PACS with open, cloud-accessible architecture

Platform · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

High quality images at low dose

Digital radiography for NICU patients

Workflow efficiency improvements

Enterprise imaging deployments

Early detection of HCC

Liver biomarker testing (AFP L3, DCP)

Aneurin Bevan University Health Board

Implementation of Synapse AI Orchestrator for enterprise-wide AI deployment and clinical workflow optimization

University Radiology Group

Implemented Synapse AI Orchestrator across all 37 medical facilities to bring AI detection and workflow efficiency advancements to mammographers for breast cancer detection

Deployed across 37 medical facilities with improved workflow efficiency and diagnostic confidence through AI-driven insights integrated directly into radiologist workflows

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

No active leadership profiles are currently listed.

06 · Company updates

Updates from FUJIFILM Healthcare Americas

Recent articles published on FUJIFILM Healthcare Americas's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Medical Imaging & Radiology

Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon